معرفی
Dr. Ciro Chiappini is a Senior Lecturer in Nanomaterials and Biointerfaces at King's College London and Associate Dean for Impact. He joined King's in 2016 after completing a Marie Curie Fellowship and Newton International Fellowship at Imperial College London (2011–2016). He holds a PhD in Biomedical Engineering from the University of Texas at Austin and an MSc in Physics from the University of Milan. His research focuses on nanotechnology, bioengineering, and cell biology to develop functional materials for regenerative and precision medicine, particularly using porous silicon nanoneedles for intracellular delivery and sensing. He has authored over 40 peer-reviewed publications, holds international patents, and was awarded an ERC Starting Grant in 2018.
Education:
- PhD in Biomedical Engineering, University of Texas at Austin (2011)
- MSc in Physics, University of Milan (2006)
Research Interests: Dr. Chiappini's work integrates nanotechnology with regenerative medicine, targeting applications such as gene editing in skin disorders (e.g., epidermolysis bullosa), intracellular drug delivery, and sensing technologies. He also explores multifunctional nanoparticles for cancer therapy and imaging. His lab develops nanoneedle-based platforms for non-invasive biopsies and corneal gene therapy.
Publications & Impact: Recent work highlights include the use of nanoneedles for correcting genetic mutations, spatiotemporal lipidomics, and scalable immune cell engineering. These studies demonstrate advancements in non-invasive diagnostics and targeted therapies.
Awards & Grants:
- ERC Starting Grant (2018)
- Marie Curie Fellowship (Imperial College London)
- Newton International Fellowship (Imperial College London)
- Active grants include projects on prenatal therapy for sickle cell disease and corneal nanoinjection platforms.
Labs & Collaborations: Leads the Chiappini Lab within the Centre for Craniofacial & Regenerative Biology. Collaborates with the London Centre for Nanotechnology and interdisciplinary teams in bioengineering, cardiology, and oncology.
